Form 4: Zimmer Biomet Group President Sells 1,000 Shares of Common Stock
Insider Transaction Report
Sang Yi, Group President of Asia Pacific at Zimmer Biomet Holdings, Inc., reported the sale of 1,000 shares of common stock for $95 per share.
Summary
- Sang Yi, the Group President of Asia Pacific for Zimmer Biomet Holdings, Inc. (ZBH), reported a transaction involving the company's common stock.
- On June 11, 2025, Mr. Yi disposed of 1,000 shares of ZBH common stock.
- The shares were sold at a price of $95 per share.
- Following this transaction, Sang Yi beneficially owns 20,424 shares of Zimmer Biomet common stock directly.
Sentiment
Score: 5
Explanation: The sentiment is neutral. An insider sale is a routine event for executives managing their equity, and the volume of shares sold is relatively small compared to the company's size and the executive's remaining holdings, thus not indicating a strong positive or negative signal.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of an insider stock transaction, common across all publicly traded companies, and does not provide specific insights into broader industry trends or competitive landscape within the medical device sector.
Stakeholder Impact
- Shareholders: A minor reduction in insider ownership, which is a common occurrence and unlikely to have a material impact on shareholder sentiment or share price given the small volume.
Key Dates
| Date | Description |
|---|---|
| 06/11/2025 | Date of common stock transaction (sale). |
| 06/13/2025 | Date the Form 4 was signed and filed. |
Keywords
Zimmer Biomet, ZBH, Insider Trading, Stock Sale, Form 4, Sang Yi, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.